With the acquisition of Best Doctors last summer, telemedicine vendor Teladoc has been providing specialist consultations through its remote platform. A less-publicized outcome of the deal, however, is that the company has also absorbed and implemented the Oncology Insight With Watson machine learning-powered second opinion service for experts providing cancer care — and it will show that at HIMSS18.
from MobiHealthNews http://ift.tt/2HUDCDB
March 01, 2018
Rose
MobiHealthNews
No comments
Related Posts:
Investors discuss booming, yet crowded, digital health industry at BIO 2018It’s no secret investors have been pouring billions of dollars into digital health companies, and it seems the life sciences sector has taken notice. Today at BIO 2018 in Boston, a panel of investors sat down to take the puls… Read More
Former Apple CEO John Sculley talks healthcare's cultural stagnation, impact of Apple, AmazonWhen it comes to the challenges of raising an up-and-coming young company into a major player in its industry, former Apple and Pepsi CEO John Sculley is no spring chicken. A serial entrepreneur and investor across numerous i… Read More
Hintsa Performance raises $7.6M for employee wellbeing platformHintsa Performance, a Finnish employee wellness tech company that formed last year when H2 Wellbeing (makers of the HeiaHeia app) merged with Hintsa Performance in 2016, has raised $7.6 million (€6.8 million) in new funding. … Read More
Headspace launches subsidiary to focus on prescription meditation apps, digital healthIt's not uncommon for doctors to tell patients that they need to relax, but now one company is aiming to develop a digital meditation product that can be prescribed by physicians. Headspace, maker of a mindfulness and meditat… Read More
92 million user accounts of MyHeritage genealogy website breachedGenealogy and DNA testing service site MyHeritage is notifying 92,283,889 users that their account information was compromised. from MobiHealthNews https://ift.tt/2HsBq4w … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment